Birdwatch Archive

Birdwatch Note

2022-02-01 07:52:37 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

“The original Reuters story misstated that ivermectin was "effective" against Omicron in Phase III clinical trials, which are conducted in humans.” Overall effectiveness is not known at this time, as this is what PIII in the trials determines. https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/

Written by 9795BF8962792425EFA8D2F4F92685B4
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1488109495440093188

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1488420004982837443
  • noteId - 1488420004982837443
  • participantId - 9795BF8962792425EFA8D2F4F92685B4
  • noteAuthorParticipantId -
  • createdAtMillis - 1643701957352
  • tweetId - 1488109495440093188
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable - BELIEVABLE_BY_MANY
  • harmful - CONSIDERABLE_HARM
  • validationDifficulty - EASY
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • “The original Reuters story misstated that ivermectin was "effective" against Omicron in Phase III clinical trials, which are conducted in humans.” Overall effectiveness is not known at this time, as this is what PIII in the trials determines. https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2022-02-01 07:52:37 UTC
(1643701957352)
1969-12-31 23:59:59 UTC
(-1)
1969-12-31 23:59:59 UTC
(-1)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)
9795BF8962792425EFA8D2F4F92685B4
2022-02-01 07:52:37 UTC
(1643701957352)
1969-12-31 23:59:59 UTC
(-1)
1969-12-31 23:59:59 UTC
(-1)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)
47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8

Note Ratings

rated at rated by
2022-02-01 13:07:32 -0600 0378F20DFECC73D3AD98390D25AA66E2BCCAAB4A22DEE65AB440D4CB6446B2E7 Rating Details
2022-02-02 14:53:33 -0600 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 Rating Details
2022-02-01 09:36:16 -0600 768C4C4EA7E7720283DD0F9889D728C4E17B575949BC8CFFC54ECE5EF81A8897 Rating Details
2022-02-01 07:48:13 -0600 A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 Rating Details
2022-02-01 07:11:50 -0600 AA10D49699E6620C77603388B971BA6E8F4081D4FF8595A608AA94ACAC6F160E Rating Details
2022-02-01 07:36:21 -0600 BE4D6C98CD88F481E8B6CC126D1EE77663FF732FA0E1A6EB77D3B11DE85705F6 Rating Details
2022-02-01 07:36:21 -0600 Rating Details
2022-02-02 14:53:33 -0600 Rating Details
2022-02-01 07:11:50 -0600 Rating Details
2022-02-01 07:48:13 -0600 Rating Details
2022-02-01 13:07:32 -0600 Rating Details
2022-02-01 09:36:16 -0600 Rating Details